-
Dried-blood spot screening for cystic fibrosis in the newborn.
Serum-immunoreactive-trypsin (I.R.T.) was measured in children with cystic fibrosis (C.F.) and a variety of controls. In the first few months of life all C.F. children had a raised serum-I.R.T. A dried blood-spot assay for I.R.T. was established and has potential as a screening test for C.F. in the newborn.
PMID: 85057 [PubMed - indexed for MEDLINE]
-
Cited by 35 PubMed Central articles
-
Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots.
Muchamore I, Morphett L, Barlow-Stewart K.
Aust New Zealand Health Policy. 2006 Dec 13; 3:14. Epub 2006 Dec 13.
[Aust New Zealand Health Policy. 2006]
-
The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.
BMC Pediatr. 2006 Oct 3; 6:25. Epub 2006 Oct 3.
[BMC Pediatr. 2006]
-
The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era.
Mishra A, Greaves R, Massie J.
Clin Biochem Rev. 2005 Nov; 26(4):135-53.
[Clin Biochem Rev. 2005]
- » See all...